USPTO serial 90141204
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erich G. Rhynhart
ONE CVS DRIVEMAILCODE: 1160WOONSOCKET, RI 02895| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business administrative services for medical referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizations | ACTIVE | Aug 29, 2016 |
| 036 | Insurance claims administration for medical claims and pharmaceuticals; processing of insurance claims and payment data | ACTIVE | Mar 15, 2017 |
| 041 | Medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services, namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposes | ACTIVE | Dec 31, 2016 |
| 044 | Medical services, namely, providing therapy management services relating to the provision of in-home and ambulatory infusion therapies and nutritional services; Medical services, namely, infusion services provided at home and in clinics; nursing services; providing medical information concerning hemophilia; Providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals, and providing hemophilia, anti-infectives, pain remediation, palliative care, cardiac, inotropic, antitrypsin deficiency, pre-transplant, post-transplant, growth hormone, hepatitis, osteoarthritis, steroid, immune deficiency, rheumatoid arthritis, multiple sclerosis, interferon, alcohol dependency, oncology, fertility, vaccine and nutritional therapy services | ACTIVE | Mar 15, 2016 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 16, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 15, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 13, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 13, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 30, 2021 | IUAF | USE AMENDMENT FILED | — |
| Sep 30, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 6, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 4, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 4, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 4, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 4, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2020 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 31, 2020 | NWAP | NEW APPLICATION ENTERED | — |